ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO007

A Multicenter Survey on Artificial Intelligence in Nephrology Education: Insights from Mayo Clinic Fellows

Session Information

Category: Educational Research

  • 1000 Educational Research

Authors

  • Sheikh, M. Salman, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Thongprayoon, Charat, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Craici, Iasmina, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Qureshi, Fawad, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Mao, Michael A., Mayo Clinic in Florida, Jacksonville, Florida, United States
  • Hommos, Musab S., Mayo Clinic Arizona, Scottsdale, Arizona, United States
  • Prendergast, Mary B., Mayo Clinic in Florida, Jacksonville, Florida, United States
  • Sukumaran Nair, Sumi, Mayo Clinic Arizona, Scottsdale, Arizona, United States
  • Kashani, Kianoush, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Cheungpasitporn, Wisit, Mayo Clinic Minnesota, Rochester, Minnesota, United States
Background

Artificial Intelligence (AI) has the potential to support clinical practice, medical education, and research. This study aimed to describe current perceptions and utilization of AI among nephrology fellows in three programs, and perform needs assessment for an educational intervention focused on AI learning.

Methods

An online survey was sent to 23 learners including fellows in general nephrology, kidney transplant, and onco-nephrology at the Mayo Clinic's three sites: Minnesota, Arizona, and Florida. The survey evaluated the current state of AI perceptions, utilization, and integration in practice. It also identified attitudes toward AI training, and perceived barriers to AI adoption in nephrology fellowship education.

Results

Of the 23 trainees, 21 completed the survey (response rate of 91%). The survey revealed that 76% of respondents have never or rarely used AI in their clinical or research activities, and none had formal AI education. However, respondents expressed a strong acknowledgment of AI's significance within nephrology, with 76% of respondents rating AI's current relevance as moderately to highly relevant to the field and 76% of fellows expressed moderate to high interest in receiving targeted AI. The majority of trainees identified interactive workshops as the preferred method of delivering AI training. The majority of fellows identified limited knowledge as the primary barrier to AI adoption. Optimism about AI's potential in nephrology was pronounced, especially for predictive modeling (86%) and diagnostic imaging (81%). However, confidence in AI for clinical decision-making remained cautious, with 33% neutral and 48% uncertain.

Conclusion

The findings underscore a significant interest among nephrology fellows in AI education, along with a critical need for formal education and training. The enthusiasm for AI's potential contrasts with a cautious perspective towards its current use in clinical decision-making, highlighting the necessity for educational initiatives that bridge the knowledge gap and foster confidence in AI technologies in Nephrology fellowship.